Identifying new potential in cancer-killing T cells
MedicalXpress Breaking News-and-Events | Dec 06, 2023
Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests
MedicalXpress Breaking News-and-Events | Nov 23, 2023
Clinical trials present a new approach using immunotherapy combinations for bladder cancer treatment
MedicalXpress Breaking News-and-Events | Nov 18, 2023
Shape-shifting immune cells offer new insights into cancer immunotherapy
MedicalXpress Breaking News-and-Events | Nov 17, 2023
Pharmaceutical compound sounds the alarm on cancer cells and unleashes T cells
MedicalXpress Breaking News-and-Events | Nov 16, 2023
How interactions between tumour genes and microenvironment influence treatment response in multiple myeloma
MedicalXpress Breaking News-and-Events | Nov 11, 2023
Epigenetically acting drugs could support cancer immunotherapy
MedicalXpress Breaking News-and-Events | Oct 26, 2023
Combining immunotherapy and radiation in soft tissue sarcoma
MedicalXpress Breaking News-and-Events | Oct 24, 2023
Cancer drug that targets two immune-evading tumour tactics performs well in early clinical trial
MedicalXpress Breaking News-and-Events | Oct 21, 2023
A pan-cancer platform to help guide patient selection for personalised immunotherapy
MedicalXpress Breaking News-and-Events | Oct 13, 2023